Axillary Lymph Nodes Suspicious for Breast Cancer Metastasis: Sampling with US-guided 14-Gauge Core-Needle Biopsy--Clinical Experience in 100 Patients
Hiroyuki Abe, Robert A. Schmidt, Kirti Kulkarni, Charlene A. Sennett, Jeffrey S. Mueller, and Gillian M. Newstead
Radiology 2008;250 41-49
Link to Journal
Axillary lymph node biopsy performed by using a 14-gauge controllable-action needle with US guidance in patients with breast cancer can yield a high positive result rate with no clinically important complications
Showing posts with label 14G core biopsy. Show all posts
Showing posts with label 14G core biopsy. Show all posts
Friday, 19 December 2008
Friday, 18 July 2008
US-guided 14-gauge Core-Needle Breast Biopsy: Results of a Validation Study in 1352 Cases
US-guided 14-gauge Core-Needle Breast Biopsy: Results of a Validation Study in 1352 Cases
Gerd Schueller, Sylvia Jaromi, Lothar Ponhold, Michael Fuchsjaeger, Mazda Memarsadeghi, Margaretha Rudas, Michael Weber, Laura Liberman, and Thomas H. Helbich
Radiology 2008;248 406-413
Link to Journal
We found agreement among US-guided 14-gauge core-needle breast biopsy results, surgical excision histologic findings, and clinical and imaging follow-up results of 95.8%, with a false-negative rate of 1.6%
Gerd Schueller, Sylvia Jaromi, Lothar Ponhold, Michael Fuchsjaeger, Mazda Memarsadeghi, Margaretha Rudas, Michael Weber, Laura Liberman, and Thomas H. Helbich
Radiology 2008;248 406-413
Link to Journal
We found agreement among US-guided 14-gauge core-needle breast biopsy results, surgical excision histologic findings, and clinical and imaging follow-up results of 95.8%, with a false-negative rate of 1.6%
Labels:
14G core biopsy,
biopsy,
concordance,
pathology,
US
Subscribe to:
Posts (Atom)